BELLINI, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 16.375
AS - Asia 9.020
EU - Europa 5.431
SA - Sud America 1.335
Continente sconosciuto - Info sul continente non disponibili 349
AF - Africa 217
OC - Oceania 23
Totale 32.750
Nazione #
US - Stati Uniti d'America 15.982
SG - Singapore 3.291
CN - Cina 2.315
IT - Italia 1.324
BR - Brasile 1.029
VN - Vietnam 946
UA - Ucraina 805
DE - Germania 784
HK - Hong Kong 740
TR - Turchia 558
GB - Regno Unito 490
PL - Polonia 410
FI - Finlandia 369
FR - Francia 301
JP - Giappone 258
BD - Bangladesh 241
RU - Federazione Russa 238
SE - Svezia 238
CA - Canada 186
IN - India 168
MX - Messico 129
ID - Indonesia 114
AR - Argentina 107
NL - Olanda 90
ZA - Sudafrica 79
IQ - Iraq 60
ES - Italia 54
BE - Belgio 53
CO - Colombia 51
AT - Austria 43
EC - Ecuador 43
CZ - Repubblica Ceca 41
EE - Estonia 37
VE - Venezuela 36
PK - Pakistan 34
PH - Filippine 32
SA - Arabia Saudita 31
MY - Malesia 28
UZ - Uzbekistan 27
MA - Marocco 26
LT - Lituania 24
IR - Iran 22
CL - Cile 21
JM - Giamaica 21
AE - Emirati Arabi Uniti 20
KR - Corea 20
PY - Paraguay 18
TN - Tunisia 18
AU - Australia 17
ET - Etiopia 17
KE - Kenya 16
NP - Nepal 16
EG - Egitto 15
BG - Bulgaria 14
DZ - Algeria 14
IE - Irlanda 14
AZ - Azerbaigian 12
CR - Costa Rica 12
RO - Romania 12
UY - Uruguay 12
PE - Perù 11
CH - Svizzera 10
JO - Giordania 10
AL - Albania 9
EU - Europa 9
IL - Israele 9
KZ - Kazakistan 9
PT - Portogallo 9
SD - Sudan 9
HN - Honduras 8
AO - Angola 7
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
NI - Nicaragua 7
OM - Oman 7
RS - Serbia 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
GE - Georgia 5
GR - Grecia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
HU - Ungheria 4
KW - Kuwait 4
PA - Panama 4
TH - Thailandia 4
DJ - Gibuti 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
QA - Qatar 3
ZW - Zimbabwe 3
Totale 32.368
Città #
Singapore 2.111
Ashburn 1.583
San Jose 1.390
Woodbridge 1.185
Fairfield 987
Chandler 927
Jacksonville 885
Santa Clara 751
Beijing 742
Hong Kong 722
Houston 719
Ann Arbor 684
Council Bluffs 531
Wilmington 412
Warsaw 391
Seattle 365
Dallas 354
Izmir 312
Cambridge 299
Ho Chi Minh City 291
Nanjing 255
Los Angeles 254
Tokyo 248
Ferrara 245
Hanoi 217
New York 208
Princeton 207
Munich 185
Boardman 171
Lauterbourg 170
Milan 156
Helsinki 127
Dearborn 123
Nanchang 95
São Paulo 91
Shanghai 88
Shenyang 87
Mexico City 81
San Diego 78
Addison 74
Buffalo 73
Toronto 69
London 68
Phoenix 68
Bologna 67
Tianjin 67
Changsha 66
Turku 66
Jakarta 65
Orem 64
Rome 63
Chicago 59
Chennai 54
Hebei 52
San Francisco 51
Bremen 50
Da Nang 50
Montreal 50
Brooklyn 48
Brussels 47
Hefei 46
Jiaxing 46
Frankfurt am Main 42
Moscow 41
Haiphong 38
Johannesburg 37
Jinan 36
Denver 35
Brno 33
Norwalk 33
Stockholm 33
The Dalles 33
Boston 32
Orange 32
Poplar 32
Ningbo 31
Vienna 31
Atlanta 30
Manchester 29
Guangzhou 28
Rio de Janeiro 28
Curitiba 27
Redwood City 25
Hải Dương 23
Augusta 22
Charlotte 22
Kunming 22
Tashkent 22
Amsterdam 21
Ankara 21
Baghdad 21
Mountain View 21
Auburn Hills 20
Belo Horizonte 20
Leawood 20
Brasília 19
Naples 19
Zhengzhou 19
Düsseldorf 18
San Mateo 18
Totale 21.124
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 420
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 333
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 309
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 282
Chimica Medica e propedeutica Biochimica 280
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 259
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 257
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 256
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 254
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 254
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 253
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 249
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 249
Evaluation of a possible role of oxidative stress in climacteric symptoms. 239
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 238
A rapid method for purification of myelin basic protein 232
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 231
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 228
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 224
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 224
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 219
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 215
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 215
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 213
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 212
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 212
Activation of the Sendai virus fusion protein by receptor binding 210
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 208
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 207
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 207
Activation of the sendai virus fusion protein by receptor binding 206
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 203
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 202
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 201
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 198
Mutual communication of envelope glycoproteins of paramixoviruses 197
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 197
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 197
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 197
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 196
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 196
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 195
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 195
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 194
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 194
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 192
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 192
Analisi della proteina basica della mielina nel liquor 191
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 190
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 189
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 188
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 187
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 186
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 186
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 183
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 182
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 181
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 180
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 180
Biochemical study in adult population with stroke in Ferrara, Fabry disease 179
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 175
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 175
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 175
A catalytic tyrosine at the active site of sendai virus neuraminidase 172
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 172
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 171
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 171
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 171
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 171
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 169
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 168
Pain in head and neck cancer patients: The role of gender 168
Anomeric specificity of the neuraminidase from sendai virus 167
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 166
Evidence for multiple pairs of vicinal thiols in some proteins 164
null 163
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 162
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 162
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 161
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 161
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 160
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 160
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 160
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 158
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 158
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 157
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 157
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 156
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 156
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 156
Sex Differences in Albumin Quotient and Cerebrospinal Fluid Total Protein Content Do Not Depend on Anthropometric Factors 155
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 155
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 154
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 154
Gender differences in audio-vestibular disorders 151
Domain structure of the hemagglutinin-neuraminidase from sendai virus 150
The effect of inorganic phosphate on the stability of some enzymes 149
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 148
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 148
Totale 19.648
Categoria #
all - tutte 150.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 888
Totale 151.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.540 0 0 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/202612.269 1.119 552 1.168 1.547 1.634 781 1.458 660 1.147 1.329 540 334
2026/20271.532 332 666 534 0 0 0 0 0 0 0 0 0
Totale 32.750